Stockreport

BofA Securities Lifts Amylyx Pharmaceuticals Inc. (AMLX) Price Target Amid Bolstered Balance Sheet [Yahoo! Finance]

Amylyx Pharmaceuticals, Inc.  (AMLX) 
PDF October 3, Bank of America Securities raised the stock's price target to $16 from $14 while maintaining a ‘Buy' rating. BofA Securities Lifts Amylyx Pharmaceuticals In [Read more]